India Advantage

iGATE Clinical Research was one of the first clinical trials management companies to establish operations in India, beginning as DiagnoSearch in 1997. Some of our clients include multinational companies such as Eli Lilly, Bayer and Pfizer. Our depth of experience in ICH-GCP clinical trials makes us nearly unique in India.

Ten Reasons to Conduct Your Next Clinical Trial in India

1. Huge patient base with large diversity of diseases
2. Heterogeneous, Caucasian population mix
3. High enrollment rates with excellent patient compliance / retention
4. State-of-the-art hospital facilities
5. Reliable, well-trained, motivated investigators
6. English-speaking medical community and source data in English
7. Demonstrated ICH GCP quality standards
8. Extremely competitive costs
9. Good communication network and IT capabilities
10. Increasingly accommodating regulatory environment

India's Medical Infrastructure
Hospitals	14,000
Doctors	500,000
Hospital beds	700,000 (85% urban)
Medical colleges	162
Medical graduates	17,000/year

India's Patient Population Estimates

• 40 million asthmatic patients
• 34 million diabetic patients
• 8-10 million people HIV positive
• 8 million epileptic patients
• 3 million cancer patients
• > 2 million cardiac related deaths
• 1.5 million patients with Alzheimer's disease
• 15% of population is hypertensive
• 1% of population suffer from schizophrenia